Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer

Somatic mutations in the gene encoding epidermal growth factor receptor (EGFR) play an important role in determining targeted treatment modalities in non-small cell lung cancer (NSCLC). The EGFR T790M mutation emerges in approximately 50% of cases who acquire resistance to tyrosine kinase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuefei, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725066/
https://www.ncbi.nlm.nih.gov/pubmed/29246024
http://dx.doi.org/10.18632/oncotarget.19007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725066/
https://www.ncbi.nlm.nih.gov/pubmed/29246024
http://dx.doi.org/10.18632/oncotarget.19007

Ejemplares similares